Zobrazeno 1 - 10
of 409
pro vyhledávání: '"Heath, Pt"'
Publikováno v:
Infection and Drug Resistance, Vol Volume 13, Pp 1263-1272 (2020)
Clara Carreras-Abad,1,2 Laxmee Ramkhelawon,1 Paul T Heath,1 Kirsty Le Doare1,3,4 1Paediatric Infectious Diseases Research Group and Vaccine Institute, Institute for Infection and Immunity, St George’s, University of London, London, UK; 2Department
Externí odkaz:
https://doaj.org/article/a93c960fe9fa4d01b2351c2bc6547c0f
Autor:
Stuart, ASV, Shaw, RH, Liu, X, Greenland, M, Aley, PK, Andrews, NJ, Cameron, JC, Charlton, S, Clutterbuck, EA, Collins, AM, Darton, T, Dinesh, T, Duncan, CJA, England, A, Faust, SN, Ferreira, DM, Finn, A, Goodman, AL, Green, CA, Hallis, B, Heath, PT, Hill, H, Horsington, BM, Lambe, T, Lazarus, R, Libri, V, Lillie, PJ, Mujadidi, YF, Payne, R, Plested, EL, Provstgaard-Morys, S, Ramasamy, MN, Ramsay, M, Read, RC, Robinson, H, Screaton, GR, Singh, N, Turner, DPJ, Turner, PJ, Vichos, I, White, R, Nguyen-Van-Tam, JS, Snape, MD, Com-COV2 Study Group
Publikováno v:
Lancet (London, England)
Snape, M D 2022, ' Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2) : a single-blind, randomised, phase 2, non-inferiority trial ', Lancet, vol. 399, no. 10319, pp. 36-49 . https://doi.org/10.1016/S0140-6736(21)02718-5
Snape, M D 2022, ' Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2) : a single-blind, randomised, phase 2, non-inferiority trial ', Lancet, vol. 399, no. 10319, pp. 36-49 . https://doi.org/10.1016/S0140-6736(21)02718-5
Background Given the importance of flexible use of different COVID-19 vaccines within the same schedule to facilitate rapid deployment, we studied mixed priming schedules incorporating an adenoviral-vectored vaccine (ChAdOx1 nCoV-19 [ChAd], AstraZene
Autor:
Shaw, RH, Liu, X, Stuart, ASV, Greenland, M, Aley, PK, Andrews, NJ, Cameron, JC, Charlton, S, Clutterbuck, EA, Collins, AM, Dejnirattisai, W, Dinesh, T, Faust, SN, Ferreira, DM, Finn, A, Green, CA, Hallis, B, Heath, PT, Hill, H, Lambe, T, Lazarus, R, Libri, V, Long, F, Mujadidi, YF, Plested, EL, Morey, ER, Provstgaard-Morys, S, Ramasamy, MN, Ramsay, M, Read, RC, Robinson, H, Screaton, GR, Singh, N, Turner, DPJ, Turner, P, Vichos, J, Walker, LL, White, R, Nguyen-Van-Tam, JS, Snape, MD, Com-COV Study Group
Background: Priming COVID-19 vaccine schedules have been deployed at variable intervals globally, which may influence immune persistence and the relative importance of third-dose ‘booster’ programmes. Here, we report on the impact of 4- versus 12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::8f66cb109597a51f09db4bdb89875e25
http://hdl.handle.net/10044/1/96621
http://hdl.handle.net/10044/1/96621
Autor:
Hill, LF, Clements, MN, Turner, MA, Donà, D, Lutsar, I, Jacqz-Aigrain, E, Heath, PT, Roilides, E, Rawcliffe, L, Alonso-Diaz, C, Baraldi, E, Dotta, A, Ilmoja, M-L, Mahaveer, A, Metsvaht, T, Mitsiakos, G, Papaevangelou, V, Sarafidis, K, Walker, AS, Sharland, M, NeoVanc Consortium
BACKGROUND: Vancomycin is the most widely used antibiotic for neonatal Gram-positive sepsis, but clinical outcome data of dosing strategies are scarce. The NeoVanc programme comprised extensive preclinical studies to inform a randomised controlled tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::f5fd524ce70abb7977c3d8122eba88f3
https://openaccess.sgul.ac.uk/id/eprint/113906/1/NeoVanc_manuscript__revised3_clean_20210915.pdf
https://openaccess.sgul.ac.uk/id/eprint/113906/1/NeoVanc_manuscript__revised3_clean_20210915.pdf
OBJECTIVES: To describe the epidemiology, age at infection, clinical characteristics and outcome of listeria infection in young infants to inform management and empiric antibiotic choice in young infants. DESIGN: Prospective 2-year surveillance of Li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::1c6f15c6556be0407d6c7313ff8b2c0f
Autor:
Miller, PDE, Patel, SR, Skinner, R, Dignan, F, Richter, A, Jeffery, K, Khan, A, Heath, PT, Clark, A, Orchard, K, Snowden, JA, de Silva, TI, Patel, S R, Heath, P T, Snowden, J A, de Silva, T I
Publikováno v:
Journal of Infection; Jan2023, Vol. 86 Issue 1, p1-8, 8p
Autor:
Feng, S, Phillips, DJ, White, T, Sayal, H, Aley, PK, Bibi, S, Dold, C, Fuskova, M, Gilbert, SC, Hirsch, I, Humphries, HE, Jepson, B, Kelly, EJ, Plested, E, Shoemaker, K, Thomas, KM, Vekemans, J, Villafana, TL, Lambe, T, Pollard, AJ, Voysey, M, Adlou, S, Allen, L, Angus, B, Anslow, R, Asselin, M-C, Baker, N, Baker, P, Barlow, T, Beveridge, A, Bewley, KR, Brown, P, Brunt, E, Buttigieg, KR, Camara, S, Charlton, S, Chiplin, E, Cicconi, P, Clutterbuck, EA, Collins, AM, Coombes, NS, Clemens, SAC, Davison, M, Demissie, T, Dinesh, T, Douglas, AD, Duncan, CJA, Emary, KRW, Ewer, KJ, Felle, S, Ferreira, DM, Finn, A, Folegatti, PM, Fothergill, R, Fraser, S, Garlant, H, Gatcombe, L, Godwin, KJ, Goodman, AL, Green, CA, Hallis, B, Hart, TC, Heath, PT, Hill, H, Hill, AVS, Jenkin, D, Kasanyinga, M, Kerridge, S, Knight, C, Leung, S, Libri, V, Lillie, PJ, Marinou, S, McGlashan, J, McGregor, AC, McInroy, L, Minassian, AM, Mujadidi, YF, Penn, EJ, Petropoulos, CJ, Pollock, KM, Proud, PC, Provstgaard-Morys, S, Rajapaska, D, Ramasamy, MN, Sanders, K, Shaik, I, Singh, N, Smith, A, Snape, MD, Song, R, Shrestha, S, Sutherland, RK, Thomson, EC, Turner, DPJ, Webb-Bridges, A, Wrin, T, Williams, CJ
Publikováno v:
Nature Medicine
The global supply of COVID-19 vaccines remains limited. An understanding of the immune response that is predictive of protection could facilitate rapid licensure of new vaccines. Data from a randomized efficacy trial of the ChAdOx1 nCoV-19 (AZD1222)
Objectives\ud This is a protocol for a Cochrane Review (intervention). The objectives are as follows:\ud \ud To evaluate the effect of enteral supplementation with synbiotics (versus placebo or no treatment, or versus probiotics or prebiotics alone)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::910b64e43b66d74b78153be654d4b57e
https://openaccess.sgul.ac.uk/id/eprint/114182/1/Sharif_et_al-2021-Cochrane_Database_of_Systematic_Reviews.pdf
https://openaccess.sgul.ac.uk/id/eprint/114182/1/Sharif_et_al-2021-Cochrane_Database_of_Systematic_Reviews.pdf
Autor:
Williams, AP, Bate, J, Brooks, R, Chisholm, J, Clarke, SC, Dixon, E, Faust, SN, Galanopoulou, A, Heath, PT, Maishman, T, Mapstone, S, Patel, SR, Vora, A, Wilding, SA, Gray, JC
Although survival rates for pediatric acute lymphoblastic leukemia are now excellent, this is at the expense of prolonged chemotherapy regimens. We report the long-term immune effects in children treated according to the UK Medical Research Council U
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::a80993e4603c48cdacd7c8eb317ed834
Importance High levels of antimicrobial resistance in neonatal bloodstream isolates are being reported globally, including in Asia. Local hospital antibiogram data may include too few isolates to meaningfully examine the expected coverage of antibiot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::473c1d7385c813cfaab45d50cef83e2a
https://ora.ox.ac.uk/objects/uuid:031d4e2a-452d-4e8c-8e33-df6e2c759db3
https://ora.ox.ac.uk/objects/uuid:031d4e2a-452d-4e8c-8e33-df6e2c759db3